PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

New computer model may aid personalized cancer care

2014-01-24
(Press-News.org) Contact information: Robbin Ray
robbin_ray@dfci.harvard.edu
617-632-4090
Dana-Farber Cancer Institute
New computer model may aid personalized cancer care BOSTON – Dana-Farber Cancer Institute scientists have developed a mathematical model to predict how a patient's tumor is likely to behave and which of several possible treatments is most likely to be effective.

Reporting in the journal Cell Reports, researchers combined several types of data from pre- and post-treatment biopsies of breast tumors to obtain a molecular picture of how the cancer evolved as a result of chemotherapy.

"Better understanding of tumor evolution is key to improving the design of cancer therapies and for truly individualized cancer treatment," said Kornelia Polyak, MD, PhD, a breast cancer researcher in the Susan F. Smith Center for Women's Cancers at Dana-Farber. The model was developed by Polyak and Franziska Michor, PhD, a computational biologist at Dana-Farber.

The study analyzed breast cancer samples from 47 patients who underwent pre-operative chemotherapy to shrink the tumor so it could be removed more easily. The biopsy samples, representing the major types of breast cancer, included specimens taken at diagnosis and again after the chemotherapy was completed.

As has been increasingly recognized, a tumor contains a varied mix of cancer cells and the mix is constantly changing. This is known as tumor heterogeneity. The cells may have different sets of genes turned on and off – phenotypic heterogeneity – or have different numbers of genes and chromosomes – genetic heterogeneity. These characteristics, and the location of different types of cells with the tumor, shape how the cancer evolves and are a factor in the patient's outcome.

In generating their predictive model, Polyak and Michor integrated data on the genetic and other traits of large numbers of individual cells within the tumor sample along with maps of where the cells were located within the tumors.

"We asked two questions – how heterogeneity influences treatment outcomes and how treatment changes heterogeneity," said Polyak. The computer model cranked out some general findings. For one, the genetic diversity within a tumor, such as differences in how many copies of a DNA segment are present – didn't change much in cancers that had no response or only a partial response to treatment.

Another result: Tumors with less genetic diversity among their cells are more likely to completely respond to treatment than are tumors with more genetic complexity. "In general, high genetic diversity is not a good thing," commented Polyak. "The results show that higher diversity is making you less likely to respond to treatment." While the genetic diversity of tumor cells was not strongly affected by chemotherapy in patients with partial or no response to treatment, the study revealed that certain types of cells – those more likely to grow rapidly – were more likely to be eliminated, and the locations of cell populations changed.

"Based on this knowledge," said Polyak, "we could predict which tumor cells will likely be eliminated or slowed down by treatment, and how this may change the tumor overall." She said this information might help design further treatment strategies for patients who didn't respond well to the initial therapy.

In the future, said the researchers, cancer doctors may use models of this type to analyze a patient's tumor at the time it's diagnosed; the results could help tailor specific drugs and plan treatment strategies matched to the tumor's predicted behavior.

First author of the report is Vanessa Almendro, PhD, of Dana-Farber/Brigham and Women's Cancer Center.

###

The research was supported by grants U54CA143874 and U54CA143798 from the National Cancer Institute and U.S Department of Energy Contract DE-AC52-07NA27344 and the Breast Cancer Research Foundation.

Dana-Farber Cancer Institute is a principal teaching affiliate of the Harvard Medical School and is among the leading cancer research and care centers in the United States. It is a founding member of the Dana-Farber/Harvard Cancer Center, designated a comprehensive cancer center by the National Cancer Institute. It provides adult cancer care with Brigham and Women's Hospital as Dana-Farber/Brigham and Women's Cancer Center and it provides pediatric care with Boston Children's Hospital as Dana-Farber/Boston Children's Cancer and Blood Disorders Center. Dana-Farber is the top ranked cancer center in New England and fifth nationally, according to U.S. News & World Report, and one of the largest recipients among independent hospitals of National Cancer Institute and National Institutes of Health grant funding. Follow Dana-Farber on Facebook and Twitter.

END



ELSE PRESS RELEASES FROM THIS DATE:

Lab-grown, virus-free stem cells repair retinal tissue in mice

2014-01-24
Investigators at Johns Hopkins report they have developed human induced-pluripotent stem cells (iPSCs) capable of repairing damaged retinal vascular tissue in mice. The stem cells, derived from human ...

A scientific first: Physicists, physicians, engineers photograph radiation beams in the human body through the Cherenkov effect

2014-01-24
(Lebanon, NH 1/22/14) — A scientific breakthrough may give the field of radiation oncology new tools ...

Putting a brake on tumor spread

2014-01-24
A team of scientists, led by principal investigator David D. Schlaepfer, PhD, a professor in the Department of Reproductive Medicine at the University of California, San Diego School of Medicine, has found that a protein ...

Exploring the roots of the problem: How a South American tree adapts to volcanic soils

2014-01-24
Soils ...

Patients receiving ADT should be counseled to improve mental and emotional well-being

2014-01-24
New York, NY, January 23, 2014 – A new study published in the Journal ...

Aspirin intake may stop growth of vestibular schwannomas/acoustic neuromas

2014-01-24
BOSTON (Jan. 24, 2014) — Researchers from Massachusetts Eye and Ear, Harvard Medical School, ...

Study identifies gene tied to motor neuron loss in ALS

2014-01-23
NEW YORK, NY (January 22, 2014) — Columbia University Medical Center (CUMC) researchers have ...

A pill 'melts away' common form of leukemia

2014-01-23
NEW YORK (January 22, 2014) -- Use of a twice-daily pill could turn a deadly blood cancer into a highly treatable disease, ...

Obesity in mothers alters babies' weight through brain rewiring

2014-01-23
Obese mothers are more likely to have children with metabolic disorders such as diabetes compared with thin mothers, but the underlying molecular and cellular reasons for this effect have been unclear. A study ...

To stay a step ahead of breast cancer, make a map of the future

2014-01-23
Cancer isn't a singular disease, even when talking about one tumor. A tumor consists of a varied mix of cells whose complicated arrangement changes all the time, especially and most vexingly as doctors and patients ...

LAST 30 PRESS RELEASES:

Research on stigma says to just ‘shake it off’

Scientists track lightning “pollution” in real time using NASA satellite

Millions of women rely on contraceptives, but new Rice study shows they may do more than just prevent pregnancy

Hot days make for icy weather, Philippine study finds

Roxana Mehran, MD, receives the most prestigious award given by the European Society of Cardiology

World's first clinical trial showing lubiprostone aids kidney function

Capturing language change through the genes

Public trust in elections increases with clear facts

Thawing permafrost raised carbon dioxide levels after the last ice age

New DNA test reveals plants’ hidden climate role

Retinitis pigmentosa mouse models reflect pathobiology of human RP59

Cell’s ‘antenna’ could be key to curing diseases

Tiny ocean partnership between algae and bacteria reveals secrets of evolution

Scientists uncover cellular “toolkit” to reprogram immune cells for cancer therapy

Blocking protein control pathway slows rhabdomyosarcoma growth in mice

2026 Hertz Fellowship Application Now Open

The gut immune system is altered in mouse model of Alzheimer’s, providing a new target for therapeutics

ADHD drugs are being prescribed too quickly to preschoolers

UCLA scientists develop off-the-shelf immunotherapy for metastatic kidney cancer

Extreme heat linked to spike in domestic violence calls in New Orleans, study finds

Mount Sinai-Duke University study identifies DNA variants that increase testosterone production in PCOS patients

Physiology-guided complete revascularization in older patients with myocardial infarction

Metals and sulfate in air pollution mixture may contribute most to asthma hospitalizations

Understanding the profound yet hidden effects of neglect on white matter structures

SEOULTECH researchers develop revolutionary 3D-printed smart materials create high-performance pressure sensors for wearables

Pusan National University scientists develop self-deploying material for next-gen robotics

Remote screening for asymptomatic atrial fibrillation

Inflammation may explain why women with no standard modifiable risk factors have heart attacks and strokes

Unusual carbon dioxide-rich disk detected around young star challenges planet formation models

Treetop Tutorials: Orangutans learn how to build their beds by peering at others and a lot of practice!

[Press-News.org] New computer model may aid personalized cancer care